Sharda Cropchem Limited has reported a strong performance for the financial year ending March 31, 2026. The company achieved a revenue of Rs. 5,268 crore, marking a 22% increase, while its profit after tax (PAT) more than doubled to Rs. 681 crore. The growth was driven by a robust product mix, expanded registrations, and significant volume momentum across global markets, culminating in a record return on capital employed of 30.4%.
Financial Performance Overview
For the full fiscal year 2026, Sharda Cropchem delivered impressive results, with revenue rising to Rs. 5,268 crore, representing a 22% year-on-year growth. Operating efficiency and scale contributed to an EBITDA of Rs. 1,040 crore, a 69% increase over the previous year. Profit after tax saw a substantial rise of 124%, reaching Rs. 681 crore, reflecting the success of the company’s asset-light business model.
Segment and Regional Highlights
The Agrochemical segment remained the primary growth driver, contributing 90% to total revenue for the year, with a segment growth of 25%. Regional performance was particularly strong in Europe, where revenue grew by 37%. The company’s diverse product portfolio saw healthy growth, led by Insecticides with a 39% increase, followed by Fungicides at 24% and Herbicides at 21%.
Strategic Outlook and Dividend
As of March 31, 2026, Sharda Cropchem maintains a robust pipeline with 3,011 product registrations and 1,004 applications currently in progress. The company continues to operate as debt-free, backed by cash and liquid investments totaling Rs. 702 crore. Recognizing this strong financial standing, the Board of Directors has recommended a final dividend of Rs. 9 per equity share. When combined with the interim dividend paid in December 2025, the total dividend payout for the year amounts to Rs. 15 per share.
Source: BSE
